E-DRUG: Webinar Apr 25 - Public funding of drug development: contributions of US NIH
-------------------------------------------------------------------------------------------------
Dear e-Druggers,
The Knowledge Network on Innovation and Access to Medicines is pleased to
invite you for the next webinar of the series presenting recent research
and analysis on topics relating to pharmaceuticals policy. We hope it is of
interest to people on this list.
Public funding of drug development: contributions of the US NIH
Thursday 25 April
4:00pm-5:00pm CEST
10:00am-11:00am EDT
To join the webinar, please register here:
https://zoom.us/webinar/register/6415553386970/WN_5bjfqPfDTSugX0KvHs9ATw
Speaker:
Dr. Ekaterina Cleary, Lead Data Analyst and Adjunct Professor at the Center
for Integration of Science and Industry, Bentley University.
Paper:
Contribution of NIH funding to new drug approvals 2010-2016
Ekaterina Galkina Cleary, Jennifer M. Beierlein, Navleen Surjit Khanuja,
Laura M. McNamee, and Fred D. Ledley
https://www.pnas.org/content/115/10/2329.long
The process to develop new medicines can be long, costly and complex, and
involve many different actors from the private, public and non-profit
sectors. While the role of the private sector is widely-recognized, there
has generally been less data and understanding of the role of public and
non-profit actors. A number of recent studies have documented the
contributions of public actors across all phases of the drug research and
development process.
Lead author Dr. Ekaterina Cleary will present a recently-published study
(above) examining US National Institutes of Health (NIH) funding associated
with 210 new molecular entities (NMEs) approved by the US Food and Drug
Administration (FDA) from 2010-2016.
The study found that NIH funding contributed to both basic and applied research associated with every one of these medicines. Dr. Cleary will explain the methodology her team used to find and analyze the relevant data, including the NIH RePORTER tool.
The conclusion suggests that the NIH contribution to drug development is
greater than previously appreciated.
To join the webinar, please refer to further instructions sent in the
confirmation e-mail after the registration has been completed using the
link above.
This event is part of the webinar series of the Knowledge Network for
Innovation and Access to Medicines, a project of the Global Health Centre
at the Graduate Institute of Geneva. Suggestions for speakers and topics
for future webinars are welcome at
globalhealthresearch@graduateinstitute.ch
Marcela Vieira
Project Coordinator
Knowledge Network for Innovation and Access to Medicines
Global Health Centre, Research
Graduate Institute of International and Development Studies
marcela.vieira@graduateinstitute.ch